Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Abbate

Showing results (141-150 of 239) with videos related to

Pageof 24
Sort By:
Haemostasis|November 1, 1993
Effect of low-dose heparin treatment on fibrinolysis in patients with previous myocardial infarctionD Prisco, R Paniccia, G F Gensini, et al.
The American Journal of Cardiology|September 2, 1998
Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplastyR Abbate, R Marcucci, O Camacho-Vanegas, et al.
Transplantation Proceedings|September 27, 2005
Venous thromboembolism in renal transplant recipients: high rate of recurrenceM Zanazzi, D Poli, E Antonucci, et al.
Thrombosis and Haemostasis|October 5, 2001
Thrombophilic risk factors in patients with central retinal vein occlusionR Marcucci, L Bertini, B Giusti, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Tissue factor and plasminogen activator inhibitor type 2 expression in human stimulated monocytes is inhibited by heparinG Pepe, B Giusti, M Attanasio, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 1988
Platelet synthesis of cyclooxygenase and lipoxygenase products in type I and type II diabetesR Abbate, S Pinto, A Panetta, et al.
Clinical Hemorheology and Microcirculation|October 24, 2012
Alterations of haemorheological parameters in patients with peripheral arterial diseaseI Ricci, F Sofi, A Alessandrello Liotta, et al.
Neuromuscular Disorders : NMD|July 10, 1999
A novel de novo mutation in the triple helix of the COL6A3 gene in a two-generation Italian family affected by Bethlem myopathy. A diagnostic approach in the mutations' screening of type VI collagenG Pepe, E Bertini, B Giusti, et al.
Thrombosis Research|October 24, 2001
Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCAD Prisco, S Fedi, E Antonucci, et al.
Cardiologia (Rome, Italy)|July 1, 1987
[Venous thrombolysis with the recombinant human tissue-type plasminogen activator (rt-PA) during the first 3 hours following acute myocardial infarction. Controlled pilot study with placebo]G Melandri, A Branzi, C Berardi, et al.
Pageof 24

Showing results (141-150 of 239) with videos related to

Sort By:
Pageof 24
Haemostasis|November 1, 1993
Effect of low-dose heparin treatment on fibrinolysis in patients with previous myocardial infarctionD Prisco, R Paniccia, G F Gensini, et al.
The American Journal of Cardiology|September 2, 1998
Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplastyR Abbate, R Marcucci, O Camacho-Vanegas, et al.
Transplantation Proceedings|September 27, 2005
Venous thromboembolism in renal transplant recipients: high rate of recurrenceM Zanazzi, D Poli, E Antonucci, et al.
Thrombosis and Haemostasis|October 5, 2001
Thrombophilic risk factors in patients with central retinal vein occlusionR Marcucci, L Bertini, B Giusti, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Tissue factor and plasminogen activator inhibitor type 2 expression in human stimulated monocytes is inhibited by heparinG Pepe, B Giusti, M Attanasio, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 1988
Platelet synthesis of cyclooxygenase and lipoxygenase products in type I and type II diabetesR Abbate, S Pinto, A Panetta, et al.
Clinical Hemorheology and Microcirculation|October 24, 2012
Alterations of haemorheological parameters in patients with peripheral arterial diseaseI Ricci, F Sofi, A Alessandrello Liotta, et al.
Neuromuscular Disorders : NMD|July 10, 1999
A novel de novo mutation in the triple helix of the COL6A3 gene in a two-generation Italian family affected by Bethlem myopathy. A diagnostic approach in the mutations' screening of type VI collagenG Pepe, E Bertini, B Giusti, et al.
Thrombosis Research|October 24, 2001
Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCAD Prisco, S Fedi, E Antonucci, et al.
Cardiologia (Rome, Italy)|July 1, 1987
[Venous thrombolysis with the recombinant human tissue-type plasminogen activator (rt-PA) during the first 3 hours following acute myocardial infarction. Controlled pilot study with placebo]G Melandri, A Branzi, C Berardi, et al.
Pageof 24